Evidence map›Paper›PMID 32885797›Full record

ArticleClinical kidney journal2020

The keys to control a COVID-19 outbreak in a haemodialysis unit.

Abraham Rincón, Francesc Moreso, Ana López-Herradón, M Amparo Fernández-Robres, Ignacio Cidraque, Jordi Nin, Orleans Méndez, Marisol López, Carlota Pájaro, Àngels Satorra and 2 more

Open access · goldAbstract read
In one paragraph

Article in Clinical kidney journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 3 pooled it
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 3 syntheses or guidelines pooled it, 53 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Asymptomatic SARS-CoV-2 infection: A systematic review and meta-analysis.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Pooled it
  4. Article
  5. Review
  6. Observational
  7. Evaluation of the relationship between COVID-19 anxiety and treatment compliance in hemodialysis patients: A prospective, descriptive study.Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy · 2022
    Article
  8. Article
  9. Review
  10. Farewell from theClinical kidney journal · 2022
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Accessing hemodialysis clinics during the COVID-19 pandemic.Transportation research interdisciplinary perspectives · 2022
    Article
  16. Article
  17. The perspectives of dialysis patients about the Covid-19 pandemic and differences between the modalities.Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy · 2022
    Article
  18. Changes in US Dialysis Dietitian Responsibilities and Patient Needs During the COVID-19 Pandemic.Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation · 2022
    Article
  19. Article
  20. A COVID-19 pandemic-specific, structured care process for peritoneal dialysis patients facilitated by telemedicine: Therapy continuity, prevention, and complications management.Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy · 2021
    Observational
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Abraham RincónMedical Department, Fresenius Medical Care Spain, Madrid, Spain.ORCID 0000-0002-6926-7120
Francesc MoresoMedical Department, Fresenius Medical Care Spain, Madrid, Spain.
Ana López-HerradónMedical Department, Fresenius Medical Care Spain, Madrid, Spain.
M Amparo Fernández-RobresHospitalet Dialysis Center, Fresenius Medical Care Spain, Hospitalet de Llobregat, Barcelona, Spain.
Ignacio CidraqueTarrasa Dialysis Center, Fresenius Medical Care Spain, Tarrasa, Barcelona, Spain.
Jordi NinHospitalet Dialysis Center, Fresenius Medical Care Spain, Hospitalet de Llobregat, Barcelona, Spain.
Orleans MéndezHospitalet Dialysis Center, Fresenius Medical Care Spain, Hospitalet de Llobregat, Barcelona, Spain.
Marisol LópezHospitalet Dialysis Center, Fresenius Medical Care Spain, Hospitalet de Llobregat, Barcelona, Spain.
Carlota PájaroTarrasa Dialysis Center, Fresenius Medical Care Spain, Tarrasa, Barcelona, Spain.
Àngels SatorraHospitalet Dialysis Center, Fresenius Medical Care Spain, Hospitalet de Llobregat, Barcelona, Spain.
Stefano StuardGlobal Medical Office - Clinical & Therapeutic Governance EMEA, Fresenius Medical Care, Bad Homburg, Germany.
Rosa RamosMedical Department, Fresenius Medical Care Spain, Madrid, Spain.
Fresenius Medical Care (Germany) · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe high rate of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spreading represents a challenge to haemodialysis (HD) units. While fast isolation of suspected cases plays an essential role to avoid disease outbreaks, significant rates of asymptomatic cases have recently been described. After detecting an outbreak in one of our HD clinics, wide SARS-CoV-2 screening and segregation of confirmed cases were performed.

methodsThe entire clinic population, 192 patients, underwent testing for SARS-CoV-2 detection by real-time reverse-transcriptase polymerase chain reaction . We used univariate and multivariate logistic regression to define variables involved in SARS-CoV-2 infection in our dialysis unit. Later, we analysed differences between symptomatic and asymptomatic SARS-CoV-2-positive patients.

resultsIn total, 22 symptomatic and 14 of the 170 asymptomatic patients had a SARS-CoV-2-positive result. Living in a nursing home/homeless [odds ratio (OR) 3.54; P = 0.026], having been admitted to the reference hospital within the previous 2 weeks (OR 5.19; P = 0.002) and sharing health-care transportation with future symptomatic (OR 3.33; P = 0.013) and asymptomatic (OR 4.73; P = 0.002) positive patients were independent risk factors for a positive test. Nine positive patients (25.7%) remained asymptomatic after a 3-week follow-up. We found no significant differences between symptomatic and asymptomatic SARS-CoV-2-positive patients.

conclusionsDetection of asymptomatic SARS-CoV-2-positive patients is probably one of the key points to controlling an outbreak in an HD unit. Sharing health-care transportation to the dialysis unit, living in a nursing home and having been admitted to the reference hospital within the previous 2 weeks, are major risk factors for SARS-CoV-2 infection.

Indexed as

asymptomatic carriersCOVID-19dialysishaemodialysisoutbreakoutcomesrisk factors

Identifiers

PMID32885797
PMCPMC7454433
OpenAlexW3082323837

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.